Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1999 Oct;107(Suppl 5):723–727. doi: 10.1289/ehp.99107s5723

Immunopathogenesis of environmentally induced lupus in mice.

V M Shaheen 1, M Satoh 1, H B Richards 1, H Yoshida 1, M Shaw 1, J C Jennette 1, W H Reeves 1
PMCID: PMC1566261  PMID: 10502537

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome defined by clinical and serologic features, including arthritis, glomerulonephritis, and certain autoantibodies such as anti-nuclear ribonucleoprotein (nRNP)/Smith antigen (Sm), DNA, and ribosomal P. Although lupus is considered primarily a genetic disorder, we recently demonstrated the induction of a syndrome strikingly similar to spontaneous lupus in many nonautoimmune strains of mice exposed to the isoprenoid alkane pristane (2,6,10,14-tetramethylpentadecane), a component of mineral oil. Intraperitoneal injection of pristane leads to the formation of lipogranulomas consisting of phagocytic cells that have engulfed the oil and collections of lymphocytes. Subsequently, pristane-treated BALB/c and SJL mice develop autoantibodies characteristic of SLE, including anti-nRNP/Sm, antiribosomal P, anti-Su, antichromatin, anti-single-stranded DNA, and anti-double-stranded DNA. This is accompanied by a severe glomerulonephritis with immune complex deposition, mesangial or mesangiocapillary proliferation, and proteinuria. All inbred mice examined appear to be susceptible to this novel form of chemically induced lupus. Pristane-induced lupus is the only inducible model of autoimmunity associated with the clinical syndrome as well as with the characteristic serologic abnormalities of SLE. Defining the immunopathogenesis of pristane-induced lupus in mice may provide insight into the causes of spontaneous (idiopathic) lupus and also may lead to information concerning possible risks associated with the ingestion or inhalation of mineral oil and exposure to hydrocarbons in the environment.

Full text

PDF
723

Images in this article

724Figure 1
on p.724
725Figure 2
on p.725
725Figure 3
on p.725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78. doi: 10.1016/s0065-2776(08)60532-5. [DOI] [PubMed] [Google Scholar]
  2. Altieri D. C., Agbanyo F. R., Plescia J., Ginsberg M. H., Edgington T. S., Plow E. F. A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem. 1990 Jul 25;265(21):12119–12122. [PubMed] [Google Scholar]
  3. Anderson P. N., Potter M. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature. 1969 Jun 7;222(5197):994–995. doi: 10.1038/222994a0. [DOI] [PubMed] [Google Scholar]
  4. Avigan J., Blumer M. On the origin of pristane in marine organisms. J Lipid Res. 1968 May;9(3):350–352. [PubMed] [Google Scholar]
  5. Beirne G. J., Brennan J. T. Glomerulonephritis associated with hydrocarbon solvents: mediated by antiglomerular basement membrane antibody. Arch Environ Health. 1972 Nov;25(5):365–369. doi: 10.1080/00039896.1972.10666187. [DOI] [PubMed] [Google Scholar]
  6. Byrd L. G., McDonald A. H., Gold L. G., Potter M. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane. J Immunol. 1991 Nov 15;147(10):3632–3637. [PubMed] [Google Scholar]
  7. Castle L., Kelly M., Gilbert J. Migration of mineral hydrocarbons into foods. 2. Polystyrene, ABS, and waxed paperboard containers for dairy products. Food Addit Contam. 1993 Mar-Apr;10(2):167–174. doi: 10.1080/02652039309374140. [DOI] [PubMed] [Google Scholar]
  8. Craft J. Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am. 1992 May;18(2):311–335. [PubMed] [Google Scholar]
  9. Finck B. K., Chan B., Wofsy D. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest. 1994 Aug;94(2):585–591. doi: 10.1172/JCI117373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fraser I., Hughes D., Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature. 1993 Jul 22;364(6435):343–346. doi: 10.1038/364343a0. [DOI] [PubMed] [Google Scholar]
  11. Hamilton K. J., Satoh M., Swartz J., Richards H. B., Reeves W. H. Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus. Clin Immunol Immunopathol. 1998 Mar;86(3):271–279. doi: 10.1006/clin.1997.4481. [DOI] [PubMed] [Google Scholar]
  12. Hess E. Drug-related lupus. N Engl J Med. 1988 Jun 2;318(22):1460–1462. doi: 10.1056/NEJM198806023182209. [DOI] [PubMed] [Google Scholar]
  13. Hill S. L., Landavere M. G., Rose N. R. The adjuvant effect of silicone gel and silicone elastomer particles in rats. Curr Top Microbiol Immunol. 1996;210:123–137. doi: 10.1007/978-3-642-85226-8_13. [DOI] [PubMed] [Google Scholar]
  14. Hultman P., Eneström S., Pollard K. M., Tan E. M. Anti-fibrillarin autoantibodies in mercury-treated mice. Clin Exp Immunol. 1989 Dec;78(3):470–477. [PMC free article] [PubMed] [Google Scholar]
  15. Jourdan M., Bataille R., Seguin J., Zhang X. G., Chaptal P. A., Klein B. Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum. 1990 Mar;33(3):398–402. doi: 10.1002/art.1780330313. [DOI] [PubMed] [Google Scholar]
  16. Kao W. J., Zhao Q. H., Hiltner A., Anderson J. M. Theoretical analysis of in vivo macrophage adhesion and foreign body giant cell formation on polydimethylsiloxane, low density polyethylene, and polyetherurethanes. J Biomed Mater Res. 1994 Jan;28(1):73–79. doi: 10.1002/jbm.820280110. [DOI] [PubMed] [Google Scholar]
  17. Kumagai Y., Shiokawa Y., Medsger T. A., Jr, Rodnan G. P. Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum. 1984 Jan;27(1):1–12. doi: 10.1002/art.1780270101. [DOI] [PubMed] [Google Scholar]
  18. Lattanzio G., Libert C., Aquilina M., Cappelletti M., Ciliberto G., Musiani P., Poli V. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. Am J Pathol. 1997 Sep;151(3):689–696. [PMC free article] [PubMed] [Google Scholar]
  19. Leak L. V., Potter M., Mayfield W. J. Response of the peritoneal mesothelium to the mineral oil, pristane. Curr Top Microbiol Immunol. 1985;122:221–233. doi: 10.1007/978-3-642-70740-7_32. [DOI] [PubMed] [Google Scholar]
  20. Marth T., Kelsall B. L. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med. 1997 Jun 2;185(11):1987–1995. doi: 10.1084/jem.185.11.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McKnight A. J., Gordon S. Membrane molecules as differentiation antigens of murine macrophages. Adv Immunol. 1998;68:271–314. doi: 10.1016/s0065-2776(08)60562-3. [DOI] [PubMed] [Google Scholar]
  22. McNally A. K., Anderson J. M. Complement C3 participation in monocyte adhesion to different surfaces. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10119–10123. doi: 10.1073/pnas.91.21.10119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nordan R. P., Potter M. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science. 1986 Aug 1;233(4763):566–569. doi: 10.1126/science.3726549. [DOI] [PubMed] [Google Scholar]
  24. Ochel M., Vohr H. W., Pfeiffer C., Gleichmann E. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol. 1991 May 1;146(9):3006–3011. [PubMed] [Google Scholar]
  25. POTTER M., BOYCE C. R. Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature. 1962 Mar 17;193:1086–1087. doi: 10.1038/1931086a0. [DOI] [PubMed] [Google Scholar]
  26. POTTER M., MACCARDLE R. C. HISTOLOGY OF DEVELOPING PLASMA CELL NEOPLASIA INDUCED BY MINERAL OIL IN BALB/C MICE. J Natl Cancer Inst. 1964 Sep;33:497–515. [PubMed] [Google Scholar]
  27. Potter M., Morrison S., Wiener F., Zhang X. K., Miller F. W. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. J Natl Cancer Inst. 1994 Jul 20;86(14):1058–1065. doi: 10.1093/jnci/86.14.1058. [DOI] [PubMed] [Google Scholar]
  28. Potter M., Wax J. S. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol. 1981 Oct;127(4):1591–1595. [PubMed] [Google Scholar]
  29. Reuter R., Tessars G., Vohr H. W., Gleichmann E., Lührmann R. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc Natl Acad Sci U S A. 1989 Jan;86(1):237–241. doi: 10.1073/pnas.86.1.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Richards H. B., Satoh M., Shaw M., Libert C., Poli V., Reeves W. H. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med. 1998 Sep 7;188(5):985–990. doi: 10.1084/jem.188.5.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rubin R. L., Bell S. A., Burlingame R. W. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest. 1992 Jul;90(1):165–173. doi: 10.1172/JCI115832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Satoh M., Hamilton K. J., Ajmani A. K., Dong X., Wang J., Kanwar Y. S., Reeves W. H. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol. 1996 Oct 1;157(7):3200–3206. [PubMed] [Google Scholar]
  33. Satoh M., Kumar A., Kanwar Y. S., Reeves W. H. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10934–10938. doi: 10.1073/pnas.92.24.10934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Satoh M., Langdon J. J., Hamilton K. J., Richards H. B., Panka D., Eisenberg R. A., Reeves W. H. Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J Clin Invest. 1996 Jun 1;97(11):2619–2626. doi: 10.1172/JCI118711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Satoh M., Reeves W. H. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994 Dec 1;180(6):2341–2346. doi: 10.1084/jem.180.6.2341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Satoh M., Treadwell E. L., Reeves W. H. Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera. J Immunol Methods. 1995 May 11;182(1):51–62. doi: 10.1016/0022-1759(95)00022-3. [DOI] [PubMed] [Google Scholar]
  37. Spickard A., 3rd, Hirschmann J. V. Exogenous lipoid pneumonia. Arch Intern Med. 1994 Mar 28;154(6):686–692. [PubMed] [Google Scholar]
  38. Sutterwala F. S., Noel G. J., Clynes R., Mosser D. M. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med. 1997 Jun 2;185(11):1977–1985. doi: 10.1084/jem.185.11.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
  40. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  41. Tang L., Eaton J. W. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med. 1993 Dec 1;178(6):2147–2156. doi: 10.1084/jem.178.6.2147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390. doi: 10.1016/s0065-2776(08)60342-9. [DOI] [PubMed] [Google Scholar]
  43. Theofilopoulos A. N. The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today. 1995 Mar;16(3):150–159. doi: 10.1016/0167-5699(95)80133-2. [DOI] [PubMed] [Google Scholar]
  44. Travis W. D., Balogh K., Abraham J. L. Silicone granulomas: report of three cases and review of the literature. Hum Pathol. 1985 Jan;16(1):19–27. doi: 10.1016/s0046-8177(85)80209-4. [DOI] [PubMed] [Google Scholar]
  45. Vyse T. J., Kotzin B. L. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol. 1998;16:261–292. doi: 10.1146/annurev.immunol.16.1.261. [DOI] [PubMed] [Google Scholar]
  46. Wanless I. R., Geddie W. R. Mineral oil lipogranulomata in liver and spleen. A study of 465 autopsies. Arch Pathol Lab Med. 1985 Mar;109(3):283–286. [PubMed] [Google Scholar]
  47. Wooley P. H., Seibold J. R., Whalen J. D., Chapdelaine J. M. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum. 1989 Aug;32(8):1022–1030. doi: 10.1002/anr.1780320812. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES